|
|
| Courses | Phar 6122 |
|
| CRP Levels. What is the deal? Current thinking on the valence of hs (high sensitivity) CRP levels are that they appear to be a a. more sensitive predictor of CVD risk than LDL-C and b. may identify a different population at risk than simply LDL-C alone. Interpretation: Perhaps both LDL-C and hs-CRP levels may be more useful than either alone for predicting risk. AHA (January 28, 2003) currently recommends measuring both LDL-C and hs-CRP in patients with a ten year Framingham risk score of >10-20%. 2) AHA Position on CRP. General summary
recommendations that for patients with 10-year Framingham risk score of
between 10-20% hs-CRP is recommended (Grade B), if <10% (Grade
C). 3) C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events. |
| [Phar 6122 Homepage] [College of Pharmacy Homepage] [University of Minnesota Homepage] |
| The University of Minnesota is an equal opportunity educator and employer. The
views and opinions expressed in this page are strictly those of the page author. The
contents of this page have not been reviewed or approved by the University of Minnesota. |
